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1  |  INTRODUC TION
Gangliosides are sialic acid containing glycosphingolipids widely 
expressed in vertebrate plasma membranes and intracellular 
compartments (Ledeen & Wu, 2011; Sandhoff & Harzer, 2013; 
Yu et al., 2011). Whilst ganglioside biosynthesis and distribu-
tion is widespread throughout the body, the nervous system 
in particular is very highly enriched in complex gangliosides 
relative to other organs and tissues. Gangliosides are present 
in both central and peripheral nervous system (CNS and PNS) 
grey and white matter, where they have roles in development 
and homeostasis, modulating cell- cell recognition, signal trans-
duction, growth and motility. Gangliosides are key components 
of lipid raft membrane domains where they have been widely 
studied (Simons & Toomre, 2000; Sonnino et al., 2015). In this 
review, we will focus our attention on the role of gangliosides 
in the maintenance of the mammalian node of Ranvier (NoR), a 
specialised membrane domain formed by myelin- forming cells: 
Schwann cells in the PNS and oligodendrocytes in the CNS 
(Figure 1). The NoR is a critical relay station in the electrophys-
iological functioning of myelinating nerve fibres, essential for 
saltatory conduction, promoted by high density clustering of 
voltage- gated sodium (Nav) channels on the nodal axolemma. 
Anchoring of the myelin paranodal loops by adhesion molecules 
and their associated cytoskeletal linker proteins in both the glial 
and axonal membranes at the paranode segregate and condense 
the ion channels (Pinatel & Faivre- Sarrailh, 2021; Rasband & 
Peles, 2021). Of note to our review, disruption to the expression 
of the paranodal axo- glial membrane protein complex composed 
of glial Neurofascin 155 (NF155), axonal contactin- associated 
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Abstract
Gangliosides are a family of sialic acid containing glycosphingolipids highly enriched in 
plasma membranes of the vertebrate nervous system. They are functionally diverse 
in modulating nervous system integrity, notably at the node of Ranvier, and also act 
as receptors for many ligands including toxins and autoantibodies. They are synthe-
sised in a stepwise manner by groups of glycosyl- and sialyltransferases in a develop-
mentally and tissue regulated manner. In this review, we summarise and discuss data 
derived from transgenic mice with different transferase deficiencies that have been 
used to determine the role of glycolipids in the organisation of the node of Ranvier. 
Understanding their role at this specialised functional site is crucial to determining dif-
ferential pathophysiology following directed genetic or autoimmune injury to periph-
eral nerve nodal or paranodal domains, and revealing the downstream consequences 
of axo- glial disruption.
K E Y W O R D S
gangliosides, glycolipid, node of Ranvier, peripheral nerve
2  |    MCGONIGAL ANd WILLISON
protein (Caspr) and Contactin markedly alters the normal con-
formation of the NoR (Bhat et al., 2001; Boyle et al., 2001; Pillai 
et al., 2009). A key readout of this includes a lengthening of 
nodal Nav channel domains and an invasion of juxtaparanodal 
voltage- gated potassium (Kv) channel domains into the paran-
ode. Whilst the protein composition at the NoR has been the 
subject of a wealth of structural and functional studies, the gly-
colipid/ganglioside component and its effects on nodal integrity 
has been less extensively studied. The composition and physiol-
ogy of PNS and CNS nodes have many similarities, but also dif-
ferences; where relevant we will highlight distinctions between 
the two sites, but in general refer to the NoR as the generic term 
for both sites. All the information contained herein refers to the 
mouse NoR, except where specified otherwise. It has long been 
known that it cannot be assumed, and has never been systemat-
ically proven, that ganglioside distribution biology is identical in 
all species (Suzuki, 1965), or indeed at all NoR which also differ 
widely according to site and nerve fibre type.
2  |  GANGLIOSIDE BIOSYNTHESIS
Gangliosides are synthesised in intracellular organelles through 
stepwise addition of donor sugars to an elongating glycan core, 
mediated by a family of developmentally and spatially regu-
lated glycolsyltransferases (Yu et al., 2011) (Figure 2a). They 
are subsequently trafficked to the plasma membrane, then re-
cycled or degraded by lysosomal exoglycosidases. The ability 
F I G U R E  1  Schematic depicting the peripheral nerve and node of Ranvier. (a) In the peripheral nervous system (PNS) nerves extend 
from their cell body to their target muscle or organ where they terminate, in this example at neuromuscular junctions (NMJ) on the muscle 
fibre. Nerves are wrapped in myelin formed by Schwann cells (oligodendrocytes in the CNS). Nodes of Ranvier (NoR) are formed by gaps 
in the Schwann cells and propagate the action potential. NoR consist of three major domains: the nodal gap is flanked by the paranodes 
(PN) where the myelin loops attach to the axon. The paranodes in turn are flanked by the juxtaparanodes (JPN). (b) Here, we depict an 
enlarged representation of a heminode. In each nodal domain there is a special arrangement of axonal and glial proteins that promotes 
the high- density clustering of ion channels. Here we depict what is currently understood about glycolipid lipid raft distribution in the 
nodal membranes and focus on their relationship to key proteins. As such, we recognise that for simplicity we have omitted a number of 
the proteins within the axons, glia and extracellular matrix that form the NoR. Paranodal axonal proteins Caspr and Contactin are likely 
highly associated with a- series gangliosides and are disturbed in their absence. Interaction with their glial binding partner neurofascin 155 
(NF155), forms the paranodal axo- glial junction. NF155 and myelin associated glycoprotein (MAG) are likely tethered by sulphatide rafts 
in the paranodal glial membrane. GD1a and GT1b are represented in the axonal paranodal ganglioside rafts as they are the major ligands 
of MAG, however, in reality the rafts could contain all complex gangliosides. Under protein/lipid deficient or pathological conditions, 
lengthening of Nav channel domains are indicated by the pink arrow, and invasion of juxtaparanodal Kv channels into the paranode, 
suggestive of breakdown of the axo- glial junction at the paranodal/juxtaparanodal border, by the green arrow
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to inactivate glycosyltransferases, through genetic deletion in 
mice (Figure 2a) or through studying natural human mutations, 
has led to many of the recent advances in understanding gan-
glioside biology (Schnaar, 2016). GM3 is the first simple gan-
glioside synthesised through the addition of α2,3- linked sialic 
acid to a lactosylceramide core. GM3 is then modified by the 
β1,4- N- acetylgalactosaminyltransferase 1 enzyme (B4galnt1 
or GalNAc- T) or by the α- 2,8- sialyltransferase (GD3 synthase, 
GD3s) enzyme to produce a- series or b- series gangliosides, re-
spectively. It is GM1 and GD1a from the a- series, and GD1b and 
GT1b from the b- series that form the majority of the ganglio-
sides expressed in the normal nervous system. The predominant 
gangliosides found in neural tissue are thus the complex gan-
gliosides GM1, GD1a, GD1b and GT1b, although many minor 
gangliosides are also expressed, likely because of high activity 
of their synthesising enzyme, GalNAc- T in the nervous system 
(Dicesare & Dain, 1971). Humans with inherited ganglioside en-
zymatic deficiency syndromes develop complex neurodevelop-
ment and degenerative disorders (Boukhris et al., 2013; Simpson 
et al., 2004). Whilst these human disorders display a widespread 
phenotype, detailed morphological analysis of the NoR has not 
to date been conducted.
3  |  GANGLIOSIDES AND OTHER 
GLYCOLIPIDS AT THE NODE OF R ANVIER
Apart from their intrinsic functional roles, gangliosides also act 
as receptors for many microbial pathogens and toxins (Bullens 
et al., 2002; Ravindran et al., 2013) and peripheral neuropathy- 
associated autoantibodies (Kusunoki et al., 2008; Willison & Yuki, 
2002). In these roles, the functional effects of ligand binding to 
gangliosides at NoRs have been determined not to induce patho-
physiological perturbations, with the exception of fairly extensive 
studies on neuropathy- associated autoantibodies as described 
below. Knowledge of the anatomical localisation of gangliosides to 
the NoR first came from studies using ganglioside binding ligands 
and antibodies, that have now been extensively conducted. Early 
studies were conducted with the GM1- binding cholera toxin B 
subunit and showed localisation on the nodal axolemma and nodal 
Schwann cell membranes, with scarce detection along the inter-
nodal Schwann cell membrane (Ganser et al., 1983). Subsequently 
a wide range of immunohistological studies with mouse monoclonal 
antibodies (McGonigal et al., 2010; Paparounas et al., 1999; Susuki 
et al., 2007a, 2007b) and human antisera (Chiba et al., 1993; De 
Angelis et al., 2001; Illa et al., 1995; Lugaresi et al., 1997; O'Hanlon 
F I G U R E  2  Glycolipid biosynthesis pathways and transgenic modifications. (a) Ganglioside and sulphatide biosynthesis pathways. Gene 
knock- outs are indicated and the transgenic lines are defined in boxes. Ceramide is the precursor to galactocerebroside (GalC), sulphatide 
and gangliosides. The cerebroside sulphotransferase (CST) enzyme synthesises sulphatide from GalC. GalNAc- transferase (GalNAc- T) 
enzyme is required to generate all complex gangliosides while the GD3 synthase (GD3s) enzyme for specific production of b- series complex 
ganglioside. This panel has been modified from Figure 1(a), McGonigal et al. (2019) (https://doi.org/10.1523/JNEUR OSCI.2095- 18.2018) 
with permission under the Creative Commons CC- BY licence (http://creat iveco mmons.org/licen ses/by/4.0/). (b) Constructs (not to scale) 
were generated to drive GalNAc- T expression in neurons of GalNAcT −/−- Tg(neuronal) mice and in glial cells of GalNAcT −/−- Tg(glial) mice. 
Dark grey shading represents all of the complex gangliosides absent in GalNAc- T −/− mice, while GD3 (light grey) is additionally absent in 
GD3s−/− x GalNAc- T −/− mice. Promotor activity leads to expression of all complex gangliosides (blue box) in the appropriate membranes in 
GalNAcT −/−- Tg(neuronal) and GalNAcT −/−- Tg(glial) mice. In the GD3s−/− x GalNAc- T −/−- Tg(neuronal) mice, only a- series complex gangliosides are 
reintroduced on neuronal membranes (orange box). Parts of this panel have been modified from Figure 1(a), Yao et al., (2014) https://doi.
org/10.1523/JNEUR OSCI.3996- 13.2014 and Figure 2(a), McGonigal et al., (2021) (https://doi.org/10.1111/jnc.15365) with permission under 
the Creative Commons CC BY- NC- SA 3.0 and CC- BY licences, respectively (http://creat iveco mmons.org/licen ses/by/4.0/)
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et al., 1998; Paparounas et al., 1999) demonstrated immunolocali-
sation of gangliosides to the nodal gap and paranodal structures, 
including GM1, GD1a and GQ1b. Much of this research was driven 
by investigators working on autoimmune neuropathy, in which anti- 
ganglioside antibody mediated injury at the node is believed to ac-
count in part for the paralytic features of disease (Griffin et al., 1996; 
Susuki et al., 2012). Since the small size of the nodal region prevents 
it from being spatially resolved either using mass- spectrometric im-
aging or biochemical isolation techniques, it has not been possible 
to unequivocally identify specific gangliosides in nodal regions, be-
yond extrapolation from immunolabelling methods. Transgenic mice 
with disruptions in specific glycosyltransferase genes, and thus defi-
cient in the composition of all downstream gangliosides, have been 
critical tools in advancing understanding of their roles at NoRs, but 
since they are generally deleted ‘en bloc’ and subject to precursor 
build up according to the enzyme position in the biosynthetic path-
way, attribution of specific functions to specific gangliosides has 
also not been possible.
3.1  |  Galactocerebroside and sulphatide
The glycolipids galactocerebroside (Galc) and sulphatide, whilst 
not gangliosides (as they lack the defining feature, sialic acid), re-
quire special mention at the NoR where they have been first and 
extensively studied in transgenic mice (Coetzee et al., 1996; Dupree 
et al., 1998; Honke et al., 2002; Hoshi et al., 2007; Ishibashi et al., 
2002). Through enzyme knockout technology, the myelin- localised 
glycosphingolipids, sulphatide and galactocerebroside were first 
shown to have a significant role in myelinated nerve maintenance. 
Their distinct or interdependent roles and interactions are unclear, 
particularly at the NoR, as GalC deficiency inevitably also leads to 
sulphatide deficiency which is downstream in the biosynthetic path-
way (Figure 2a). Disruption of UDP- galactose:ceramide galactosyl 
transferase (CGT) results in mice that are incapable of synthesising 
either of these lipids; mice thus express a severe dysmyelinating 
phenotype including NoR disruption, which is more severe in the 
CNS than PNS (Coetzee et al., 1996; Dupree et al., 1998). Sulphatide, 
3- O- sulphogalactosylceramide, synthesised from GalC through the 
addition of a 3- O- sulphate group by cerebroside sulphotransferase 
enzyme (CST), is enriched in the outer leaflet of the myelin and 
uncompacted glial membranes (Ishizuka, 1997) and small amounts 
are present in neurons and astrocytes (Eckhardt, 2008). Evidence 
from CST −/− mice indicates that sulphatides are crucial for the main-
tenance and stability of the NoR (Honke et al., 2002; Hoshi et al., 
2007; Ishibashi et al., 2002). Indeed, in the absence of sulphatide, 
loss of NF155 immunostaining suggests a role in tethering this 
key paranodal axo- glial adhesion molecule to the glial membrane 
(Hoshi et al., 2007; McGonigal et al., 2019). However, only recently, 
owing to the development of new anti- sulphatide antibodies, have 
F I G U R E  3  Anti- sulphatide and anti- ganglioside antibody binding patterns at the peripheral nerve node of Ranvier. (a) This panel has 
been modified from Figure 4(a), Meehan et al. (2018) (https://doi.org/10.1016/j.jneur oim.2018.07.004) with permission under the Creative 
Commons CC- BY licence (http://creat iveco mmons.org/licen ses/by/4.0/). Anti- sulphatide antibody binding along the myelin and at the 
paranodal loops (green, *) was observed in the peripheral nerves (magenta) of wild- type mice, while no binding was detected in CST −/− mice, 
thus demonstrating the specificity of the antibody to sulphatide. (b) Sciatic nerves were exposed to anti- GM1 antibody and show selective 
neural membrane binding among transgenic mice. In wild- type mice, antibody could be detected at the nodal gap (co- localised with nodal 
protein gliomedin (Gldn, arrowhead) and the paranodal loops (*). No antibody staining was detected in ganglioside deficient GalNAc- T −/− mice, 
demonstrating antibody specificity to GM1. Antibody binding was restricted to the nodal gap in Neuronal nerve (GalNAcT −/−- Tg(neuronal) 
mice), and to the paranodal loops in Glial nerve (GalNAcT −/−- Tg(glial) mice), demonstrating the membrane selective expression of complex 
gangliosides in these transgenic mice. Scale bar = 10 µm
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F I G U R E  4  Schematics depicting the likely impact of increasing glycolipid deficiency on paranodal arrangement at nodes of Ranvier based 
on known data from the PNS and CNS. Particular focus is placed on the paranodal axo- glial proteins Caspr, NF155 and MAG about which 
most is known. Lengthening of Nav channel domains are indicated by the pink arrow and invasion of juxtaparanodal Kv channels into the 
paranode suggestive of breakdown of the axo- glial junction at the paranodal/juxtaparanodal border, by the green arrow. The transgenic 
lines represented by each stage of nodal organisation are defined below the relevant schematic, and age is also defined. In ganglioside 
deficient states, there is nodal lengthening, followed by Caspr/NF155 disturbance and Kv1.1 invasion into the lateral paranode. Normally 
GD1a and GT1b in rafts will tether MAG but in their absence, MAG does not make the axo- glial connection. If NF155 is present, this protein 
can partner with Caspr/Contactin to make an axo- glial junction. However, when sulphatide is absent, NF155 is also lost from the paranode. 
In the absence of NF155, Caspr presence is also diminished, and this is exacerbated with the additional loss of complex ganglioside rafts. 
Under both ganglioside and sulphatide raft deficiency, we propose that MAG and NF155 are both absent from the paranodal axo- glial 
domain. This figure uses schematics modified from Figure 8, McGonigal et al., (2019) (https://doi.org/10.1523/JNEUR OSCI.2095- 18.2018) 
with permission under the Creative Commons CC- BY licence (http://creat iveco mmons.org/licen ses/by/4.0/)
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immunolabelling studies shown that sulphatide appears highly en-
riched in paranodal loops, as well as being present along the Schwann 
cell membrane (Meehan et al., 2018) (Figure 3a).
3.2  |  Complex gangliosides
The advent of glycosyltransferase transgenic mice lacking specific 
ganglioside species revealed both myelin and nodal disorganisation 
as a result of different deficiencies, thereby inferentially indicat-
ing a role for gangliosides in nodal organisation and maintenance 
(McGonigal et al., 2021; Susuki et al., 2007a; Yamashita et al., 2005).
The first mouse generated and relevant to the NoR had dis-
ruption in the B4galnt1 gene and thus deficiency in GalNAc- T 
(Takamiya et al., 1996). These mice are viable and appear grossly 
normal, indicating that complex ganglioside expression is not 
necessary for normal development, but later develop an age- 
dependent neurodegenerative phenotype characterised by weak-
ness, ataxia, motor deficits, nerve degeneration and demyelination 
(Chiavegatto et al., 2000; Sheikh et al., 1999; Takamiya et al., 1996). 
In particular, loss of nodal axo- glial junction adhesion and integrity, 
disrupted paranodal loop attachment, invasion of voltage- gated 
potassium channels from the juxtaparanode to the paranode co-
inciding with attenuated paranodal Caspr and NF155 immunos-
taining at this border was observed (Susuki et al., 2007a). In these 
mice, overexpression of the precursor simple gangliosides GM3, 
GD3 and 9- O- Ac(etyl)- GD3 may play a compensatory develop-
mental role that limits the severity of the phenotype (Furukawa 
et al., 2008; Ngamukote et al., 2007). Mice deficient in GD3 syn-
thase and thus lacking b- series gangliosides whilst over- expressing 
a- series gangliosides (GD3s−/−) are grossly normal throughout life 
but repair peripheral nerve poorly (Okada et al., 2002). Nodal 
abnormalities have not been observed to date in GD3s−/− mice 
(McGonigal et al., 2010; Susuki et al., 2007a) which could indicate 
the particular importance of a- series gangliosides in maintaining 
the NoR. Mice whose ganglioside repertoire is restricted to GM3 
(GalNAc- T and GD3s double knock- out) develop lethal audiogenic 
seizures (Kawai et al., 2001), age- dependent progressive motor 
and cognitive deficits (Tajima et al., 2009), and sensory loss (Inoue 
et al., 2002). The NoR in GM3 only mice was recently reported to 
show similar disruptions in nodal immunostaining to those found 
in GalNAc- T −/− mice (McGonigal et al., 2021), confirming the sig-
nificance of complex gangliosides to this site as further loss of 
GD3 added minimal impact. Complete ganglioside ablation is not 
embryonic lethal; however, from 2 weeks of age, mice undergo 
progressive and severe neurodegeneration resulting in death at 
2 months although the contribution of nodal dysfunction to this 
has not been assessed (Yamashita et al., 2005). Most ganglioside 
deficient mice display age- dependent abnormalities but are not as 
severely impaired as nodal protein null mice which have a marked 
reduction in life- expectancy. Additionally, CNS NoR are often more 
perturbed than PNS NoR, which could reflect the greater influence 
that the paranode bestows on CNS stability (Rasband & Peles, 
2015). Together, these mouse data are suggestive of a more fun-
damental necessity for a- series gangliosides in age- related nervous 
system maintenance, although this is difficult to conclusively prove 
because a mouse with selective deficiency of a- series gangliosides 
has not been generated.
3.3  |  Gangliosides, sulphatide and myelin- 
associated glycoprotein
A specific and interesting issue at the NoR relates to interactions 
between the glial myelin- associated glycoprotein (MAG) and gan-
gliosides. The complex gangliosides GD1a and GT1b have been 
identified as axonal ligands for MAG (Collins et al., 1997; Vinson 
et al., 2001) (see Figure 2a), localised on the innermost wrap of 
the myelin sheath, paranodal loops and Schmidt- Lanterman in-
cisures where glial cytoplasm is present (Bartsch et al., 1989; Trapp 
et al., 1989). The age- related degenerative phenotype, functional 
and morphological deficits displayed by GalNAc- T −/− mice paral-
lel those found in MAG−/− mice, both showing greater severity in 
the CNS than the PNS. Interestingly, generation of double deficient 
mice created from interbreeding GalNAcT −/− and MAG−/− genotypes 
did not further exacerbate the phenotype of the single- null mice. 
This suggests a complementary and functional interaction be-
tween complex gangliosides and MAG in nerve integrity (Pan et al., 
2005). Mice that lack key sialylation enzymes proposed to generate 
both GD1a and GT1b show a significant reduction in brain MAG 
immunostaining that coincides with abnormal nervous system 
development showing the specificity of this interaction (Sturgill 
et al., 2012). With the knowledge that both MAG and galactolip-
ids modulate axo– glial stability, Marcus et al. (2002) investigated 
the significance of both molecules to axo– glial integrity by crossing 
MAG deficient mice with GalC/sulphatide double- deficient mice, 
which individually have similar phenotypes. This genetic combina-
tion resulted in a lethal phenotype, with survival up to post- natal 
day 22 (P22). Again, the NoR appear to develop normally followed 
by subsequent generalised impairment of the paranodal axo– glial 
junction.
We advanced these studies to consider the compensatory roles 
of complex gangliosides and sulphatide in maintaining axo- glial 
stability at NoR by combining GalNAc- T −/− and CST −/− strains and 
examining the nodal phenotype (McGonigal et al., 2019). Depletion 
of both gangliosides and sulphatide exacerbated the phenotype, 
suggesting two independent roles. In these animals, a severe neu-
rodevelopmental phenotype occurred with early death around P22. 
Degenerating axon number increased with diminishing lipid content 
and conduction became increasingly impaired. MAG expression in 
the myelin fraction from brain homogenates was significantly lower 
in the CST −/− x GalNAc- T −/− genotype compared with single defi-
ciency genotypes and Nav channel cluster number, Caspr dimer 
number, and Nav channels flanked by NF155 dimers decreased with 
decreasing lipid expression. Once again the nodal phenotype was 
more severe in CNS compared to PNS nerve. Since MAG acts as a 
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myelin receptor for axonal gangliosides and also may be localised to 
the myelin membrane by sulphatide- rich lipid rafts, loss of both the 
axonal and glial membrane localisation domains for MAG could con-
tribute to this severe phenotype. A progressive reduction in MAG 
and a significant reduction in NF155 (25% compared to wild type) in 
CST −/− mouse brains was recently reported (Palavicini et al., 2016), 
and extraction studies have suggested that sulphatide- containing 
lipid rafts could be anchors for MAG and NF155 (Pomicter et al., 
2013). Taken together, it seems that glial sulphatide may act as a 
wide- ranging anchor for multiple myelin and glial membrane pro-
teins in a complementary and interdependent relationship with ax-
onal gangliosides.
4  |  USE OF TISSUE SPECIFIC TR ANSGENIC 
MICE TO STUDY GANGLIOSIDE 
FUNC TION AT THE NODE OF R ANVIER
Whilst the above studies have indicated that complex gangliosides 
are required for nervous system maintenance, stability and repair 
including the NoR, it is unknown whether neuronal or glial ganglio-
side deficiency has the greater impact on the age- related pheno-
type and maintenance of the axon, myelin and axo- glial junction. 
Unlike GalC and sulphatide, which are almost exclusively localised 
to glial membranes, gangliosides are expressed in both glia and 
neurons (Gong et al., 2002; Ogawa- Goto & Abe, 1998), and thus 
function cannot be precisely attributed to tissue expression. An 
added complexity is that gangliosides can transfer between mem-
branes by shedding and uptake (Heffer- Lauc et al., 2005; Olshefski 
& Ladisch, 1996), potentially confounding the concept of discrete 
membrane localisation. Additionally there is likely to be heterogene-
ity in ganglioside lipid raft composition within a single membrane; 
for example distinct separation between GM1- and GD3- containing 
rafts has been reported (Vyas et al., 2001). To assess the relative sig-
nificance and necessity of complex ganglioside expression in either 
neuronal or myelin- forming cells, we developed “rescue” mice. On 
a GalNAc- T −/− background, these rescue mice selectively express 
gangliosides either neuronally [GalNAc- T being driven by the neu-
rofilament light (NFL) or Thy1 promoters: GalNAcT −/−- Tg(neuronal)] 
or in myelin [GalNAc- T being driven by the proteolipid protein (PLP) 
promoter: GalNAcT −/−- Tg(glial)](McGonigal et al., 2016; Yao et al., 
2014) (Figure 2b). Through this selective reintroduction of glyco-
syltransferase activity in a site- specific manner, we observed that 
neuronal, and not glial, rescue of complex gangliosides was both 
necessary and sufficient to prevent the age- dependent neurode-
generative phenotype seen in global GalNAcT −/− deficiency states 
(Yao et al., 2014). Despite the potential for ganglioside transfer be-
tween membranes as mentioned above, we detected no evidence of 
this transfer between axons and glia, or vice versa in our transgenic 
rescue mice. Additionally, there was a selective absence of ganglio-
side expression in primary cultured neurons or glial cells from our 
GalNAcT −/−- Tg(glial) or GalNAcT −/−- Tg(neuronal) transgenic lines, re-
spectively, which validated the use of the cell- specific promotors. 
These findings clearly demonstrate the prime importance of neu-
ronally expressed GalNAc- T in maintaining nervous system integrity 
throughout the lifespan.
With specific reference to the NoR, we considered that, because 
these glycolipids are differentially expressed in glial and axonal mem-
branes (Figure 3b), they may act in partnership to retain clustered 
proteins in their respective domains. There is evidence that complex 
ganglioside deficiency can disturb lipid raft associated anchoring of 
membrane proteins as has been shown for complement regulators 
(Ohmi et al., 2011). Axonal Caspr and glial NF155 have been pro-
posed to be in lipid rafts (Schafer et al., 2004), and ganglioside loss 
disrupts these raft- associations which coincides with loss of paran-
odal integrity (Susuki et al., 2007a). We sought to test the impor-
tance of specific ganglioside membrane expression by interbreeding 
strains of single- null mice and neuronal- and glial- specific rescue 
mice, thereby allowing us to assess interdependency and cooperativ-
ity in the role of axonal and glial glycolipids in paranodal organisation. 
The expression of a- and b- series gangliosides neuronally reversed 
the age- dependent breakdown of the axo- glial junction in both the 
PNS and CNS, demonstrated by invasion of Kv channels from the 
juxtaparanode to the paranode in GalNAc- T −/− mice (Yao et al., 2014). 
Glial ganglioside expression exacerbated rather than improved the 
phenotype. It is interesting to note that aged GalNAc- T −/−- Tg(neuronal) 
NoR did not completely return to a wild- type arrangement; the Nav 
channel clusters remained lengthened, and the Caspr domains were 
longer compared to all other genotypes. We further demonstrated 
that neuronal expression of a- series complex gangliosides could 
promote survival in the GalNAc- T x GD3s (i.e. GM3- only) double 
null mice, but complete restoration to normal would likely require 
b- series expression (McGonigal et al., 2021). In these mice, both CNS 
and PNS NoR showed only partial recovery to wild- type composition 
with the expression of a- series complex gangliosides. Shortening of 
NF155 and Caspr domains indicating loss of axo- glial integrity was 
more severe in the CNS and minimally improved. Notably, recovery 
of nodal protein organisation was dependent on the proteins locali-
sation in either the neuronal or glial membrane. Glial neurofascin 155 
was normalised with the expression of neuronal a- series gangliosides, 
likely owing to the contribution of glial sulphatide, but axonal jux-
taparanodal Kv channels, Caspr domains and Nav channel clusters 
remained disrupted, suggesting the need for a contribution from b- 
series gangliosides. This suggests the requirement of specialised lipid 
raft associated anchoring domains that involve gangliosides. We feel 
this builds upon the work by Schafer et al. (2004) who proposed the 
formation of a paranodal lipid raft protein adhesion complex and 
strengthens the concept that Caspr requires two stabilising mech-
anisms: protein– protein and protein– lipid interactions that promote 
stability of the paranodal axo– glial junction (McGonigal et al., 2021).
Rescuing the neuronal, but not the glial, complex ganglioside expression 
reversed the lethality observed in the CST −/− x GalNAc- T −/− double null 
mice (McGonigal et al., 2019). Examining the relative importance of a- and 
b- series gangliosides, we observed that only modest improvement occurred 
with global a- series ganglioside expression on a sulphatide- null background. 
Similarly, normal CNS NoR composition in the absence of sulphatide and 
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complex gangliosides could be improved by a- and b- series gangliosides, and 
not with global a- series ganglioside expression. Collectively, these data indi-
cate the importance of neuronal b- series gangliosides (e.g., GD1b and GT1b) 
in maintaining survival in the co- presence of sulphatide deficiency and indi-
cate interdependency between the functions of these two groups of lipids.
These results suggest that the composition of the NoR is largely 
governed by neuronal a- series gangliosides, but that they are not 
completely sufficient for a normal phenotype. We thus propose that 
sulphatide and b- series ganglioside lipid domains on opposing mem-
branes majorly contribute to a coordinated axo– glial adhesion and 
paranodal organisation, a combined loss of which leads to severe 
impairment of nerve integrity with a fatal outcome at an early age. 
Based on all of the studies discussed, we have created a series of 
schematics that represent the effect on nodal integrity of progres-
sive glycolipid loss from neural membranes (Figure 4).
5  |  USE OF TISSUE SPECIFIC TR ANSGENIC 
MICE TO STUDY AUTOIMMUNE INJURY TO 
THE NODE OF R ANVIER
As previously published data described in section 4 shows, generation of 
the rescue mice provides the previously unfeasible opportunity to char-
acterise the contribution of membrane- specific ganglioside expression 
on nerve integrity and biological function. Additionally, they provide the 
ideal system for selectively targeting neural membranes at the NoR and 
determining the downstream consequences of site- specific autoimmune 
injury. Indeed, understanding the NoR pathophysiology of the human 
disease Guillain- Barré syndrome (GBS) has been the motivation for gen-
erating these mice and the subject of future publications. This anticipates 
a significant step forward as there exists a few enigmas within the field 
of inflammatory neuropathies associated with anti- ganglioside antibod-
ies. Autoantibodies against gangliosides, expressed on both axonal and 
glial membranes, can be particularly associated with clinical syndromes 
dominated by specific cellular injury to only one. An example of this is the 
motor form of the peripheral neuropathy GBS, acute motor axonal neu-
ropathy (AMAN), where motor axons appear to undergo selective injury 
in comparison with glial membranes (Feasby et al., 1986; Hafer- Macko 
et al., 1996). Traditionally, GBS cases are categorised as axonal or demy-
elinating variants depending on the presumed site of injury. However, it 
is becoming clear that this rigid classification system does not satisfacto-
rily define patients and their symptoms. For example, patients with nodal 
dysfunction or disruption can have a spectrum of symptoms ranging from 
reversible conduction block to axon degeneration leading to quite dif-
ferent prognoses. There has been extensive discussions on the relative 
contribution nodal membrane injury can impart on nerve function in dis-
ease, and the concept of nodo- paranodopathy versus distinct axonal or 
demyelinating variants is gaining acceptance as a way to understand the 
pathophysiological continuum, especially pertaining to anti- ganglioside 
antibody driven disease at the NoR (Uncini et al., 2013).
Given the minor nodal abnormalities observed in aged rescue mice, 
it was essential to characterise the NoR at the age to be used in ex-
perimental studies. Herein, we also include data on a further neuronal 
and glial double rescue mouse. It has recently been reported that circu-
lating anti- ganglioside antibodies can be sequestered by global ganglio-
side membrane expression in wild- type mice (Cunningham et al., 2016) 
rendering their use for passive immunisation injury studies limited. We 
observed this finding in wild- type mice on a C57BL/6 background and 
do not know if it can be generalised to other strains. Cunningham et al. 
(2016) showed that this phenomenon does not occur in single neuronal 
or glial rescue mice, and as such injury models using these mice are pos-
sible (McGonigal et al., 2016). It is our expectation that double rescue 
mice can substitute wild- type mice where we see no sequestration of 
anti- ganglioside antibody, but gangliosides are expressed on both neural 
membranes. Below we include the nodal characterisation of this newly 
generated double rescue line compared to the original transgenic mice.
At 4– 6 weeks of age, there appears to be little detectable im-
pact of membrane selective complex ganglioside expression on 
nodal organisation (Figure 5). There are no significant differences in 
the length of Nav channel clusters, Caspr domains, pan- neurofas-
cin (pan- NFasc) domains or the gap between Kv1.1 channel dimers 
among the genotypes analysed in this study. Direct comparison be-
tween wild- type and GalNAc- T −/− nerve, showed subtle abnormal-
ities in these parameters, also reported previously by Susuki et al. 
(2007a) at this age. Similar to GalNAc- T −/− mice, we did observe a 
slight preponderance of glial mice to exhibit mild Kv1.1 invasion into 
the juxtaparanodal border of the paranode (indicated in Figure 5), 
and would not recommend their use at older ages as this could indi-
cate the early stages of the disrupted nodal phenotype.
Having established the normal nodal organisation, we assessed 
the potential for selective nodal targeting by pathogenic antibody. 
Using a single anti- GM1 antibody, we show the differential binding 
patterns at the NoR among wild- type, GalNAc- T −/−, neuronal, and 
glial ganglioside rescue mice. Figure 3b shows binding at both the 
nodal gap and paranodal loops in wild- type mice and an absence of 
any labelling in GalNAc- T −/− mice. Antibody binding is restricted to 
the nodal axolemma in neuronal rescue mice and to the paranodal 
loops in glial rescue mice. These results make these mice ideal for 
studying the downstream consequences of antibody binding to dif-
ferent neural membranes at the NoR. Knowing that the rescue mice 
do have an abnormal expression of gangliosides and are prone to 
show age- dependent decline in structure, it will be prudent to take 
this into consideration when interpreting results. However, the cur-
rent immunohistological data demonstrate that the NoR are grossly 
normal in all of the lines studied at this age, thereby confirming their 
suitability for use in peripheral nerve injury models going forward.
6  |  CONCLUSION
Transgenic manipulation of glycosyltransferases has provided a 
wealth of information on the roles of gangliosides and glycolipids 
in stabilising specialised membrane domains at the NoR. Whilst 
knockout studies on many nodal proteins has provided extensive 
and definitive information on nodal biology, the functional roles 
of glycolipids are much more complex to investigate and nuanced, 
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owing to redundancy and inability to knockout specific ganglio-
sides. Nevertheless, it is clearly evident that the NoR is rich in gly-
colipids that function to maintain its integrity and can play a role 
in pathology. Our rescue mice provide an invaluable tool to explore 
this field further. It is clear that the NoR is enriched in glycolipids, 
and whilst this has been the focus of this review, it does not detract 
F I G U R E  5  (a) Peripheral nerve nodal organisation is unchanged among mice with selective neural membrane ganglioside expression. 
Sciatic nerve from 4 to 6 week old wild- type, Neuronal (GalNAc- T −/−- Tg(neuronal)), Glial (GalNAc- T −/−- Tg(glial)), Neuronal x Glial, and GalNAc- 
T −/− mice were analysed (n = 3/ genotype). There were no significant differences among the genotypes in the gap between juxtaparnodal 
Kv1.1 domains, pan neurofascin (pan- NFasc, binds both neurofascin 155 and 186) domain length, Caspr domain length or Nav channel 
cluster length (one- way ANOVA, p > 0.05). (b) Illustrative merged images show immunostaining for: top panel Kv1.1 (orange) and Caspr 
(magenta); bottom panel pan- NFasc (orange) and Nav channels (magenta). Caspr immunostaining was located at the paranodes and flanked 
by juxtaparanodal Kv1.1 in all nerves. Distinct Nav channel clusters were flanked by pan- Nfasc domains (presumed glial NF155). Paranodal 
invasion was occasionally observed in Glial and GalNAc- T −/− mice (indicated by arrowhead). Scale bar = 5 µm
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from the important and specialised roles gangliosides have in other 
domains of the nervous system under investigation elsewhere. We 
anticipate that the legacy of our mice will be their use in exploring 
and understanding the emerging roles of gangliosides in the nervous 
system within selective membranes at the NoR and beyond.
7  |  METHODS
7.1  |  Mice
We used 4– 6 week old mice, both male and female, from five mouse 
lines all on a C57BL/6J background: (a) wild- type; (b) GalNAc- T −/−; 
(c) GalNAc- T −/−- Tg(neuronal); (d) GalNAc- T −/−- Tg(glial); (e) GalNAc- T 
−/−- Tg(neuronal/glial). GalNAc- T −/− mice lack all complex gangliosides 
globally (Takamiya et al., 1996), while GalNAc- T −/−- Tg(neuronal) and 
GalNAc- T −/−- Tg(glial) mice have reconstituted site- specific expression of 
complex gangliosides on neuronal (McGonigal et al., 2016) or glial (Yao 
et al., 2014) membranes, respectively. GalNAc- T −/−- Tg(neuronal/glial) 
were generated by interbreeding GalNAc- T −/−- Tg(neuronal) and 
GalNAc- T −/−- Tg(glial) mice. Mice were maintained under a 12h light/
dark cycle at controlled temperature and humidity with ad libitum ac-
cess to food and water. Mice were killed by a rising CO2 inhalation; all 
experiments using mice were performed in accordance with a license 
(POC6B3485) approved and granted by the United Kingdom Home 
Office and conformed to University of Glasgow institutional guidelines. 
Experiments complied with relevant guidelines on the care and use of 
animals outlined in the revised Animals (Scientific Procedures) Act of 
1986.
7.2  |  Anti- ganglioside antibody immunostaining
Sciatic nerves were rapidly dissected and desheathed in oxygen-
ated (95% O2 and 5% CO2) physiological Ringer's solution containing 
the following (in mM): NaCl, 129; KCl, 3; NaH2PO4, 1.2; CaCl2, 2.4; 
MgSO4 1.3; HEPES, 3; NaHCO3, 20 and glucose, 10. Nerves were 
incubated for 1 h at 4℃ in 100µg/ml anti- GM1 IgG3 antibody that 
has been generated as previously described (Boffey et al., 2005; 
Townson et al., 2007). Nerves were washed and fixed in 4% PFA 
for 30 min at 4℃, then washed in three 10 min changes of PBS, 
0.1 M glycine and PBS. Sciatic nerves were gently teased out into 
single fibres onto APES coated slides. Slides were incubated over-
night at 4℃ in blocking solution (0.3% Triton +3% normal goat 
serum) with rabbit anti- gliomedin antibody (Gldn, Abcam #ab24483, 
RRID:AB_2111616; 1:100). Nerves were washed with PBS followed 
by application of Alexa Fluor 488- conjugated goat anti- mouse IgG3 
(Thermo Fisher Scientific Cat# A- 21151, RRID:AB_2535784; 1:500) 
and Alexa Fluor 555- conjugated goat anti- rabbit IgG (Thermo Fisher 
Scientific Cat# A- 21429, RRID:AB_2535850; 1:500) in PBS with 
3% NGS for 2h at R.T. Slides were washed in PBS and mounted in 
Citifluor.
7.3  |  Nodal Immunostaining
Sciatic nerves (n = 3/genotype) were rapidly dissected into 4% PFA 
and incubated for 30 min at 4℃. The nerve was washed in three 
changes of PBS and moved to 30% sucrose for 1 h at 4℃. Nerves 
were embedded in OCT mount medium and 10 µm longitudinal sec-
tions collected onto APES coated slides. Slides were pre- treated 
with 100% EtOH at −20℃ for 10 min, thoroughly washed in PBS, 
before application of a blocking solution (0.3% Triton +10% nor-
mal goat serum) for 1 h at 4℃. Slides were then incubated over-
night at 4℃ with either one of the following combinations of 
primary antibodies: rabbit anti- voltage- gated potassium channel 
(Kv1.1, Alomone Laboratories #APC- 009; RRID:AB_2040144; 
1:200) plus mouse anti- Caspr (Antibodies incorporated #75- 001; 
RRID:AB_ 2083496; 1:300); rabbit anti- pan neurofascin (anti- pan- 
NFasc; gifted from Professor Brophy, University of Edinburgh, 
UK; 1:1000) plus mouse anti- pan voltage- gated sodium channel 
(pNav; Sigma- Aldrich #8809; RRID:AB_477552; 1:100). Following 
washes in PBS, slides were incubated with secondary antibodies 
prepared in PBS plus 1% NGS for 2 h at R.T. as follows: Alexa Fluor 
555- conjugated goat anti- rabbit IgG (Thermo Fisher Scientific Cat# 
A- 21429, RRID:AB_2535850; 1:500); Alexa Fluor 647- conjugated 
goat anti- mouse IgG1 antibody (Thermo Fisher Scientific Cat# A- 
21240, RRID:AB_2535809; 1:500). After PBS washes, slides were 
mounted in Citifluor.
7.4  |  Imaging and analysis
Images were captured at 40x or 63x magnification using a Zeiss 
AxioImager Z1 with ApoTome attachment and processed with Zeiss 
Zen 2 blue edition software. For each staining combination, 5– 10 
z- stacks (step value 0.4 µm) were captured per mouse. For periph-
eral nerve node analysis, images were used to quantify the length 
of the Nav channel clusters, pan- NFasc and Caspr domains, and the 
distance between Kv1.1 dimers from 35 to 90 nodes of Ranvier per 
mouse. Results were plotted as the average length ±SEM. The tissue 
was coded upon collection, thereby the experimenter performing 
analysis was blinded and unaware of the genotype. Statistical dif-
ferences among genotypes were determined by one- way ANOVA 
followed by Tukey's post- hoc test using GraphPad Prism 6 software 
(RRID:SCR_002798). Differences were considered significant when 
p < 0.05.
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